International Association for the Study of Lung Cancer Global Survey on Biomarker Testing
Improve global lung cancer biomarker testing rates and reduce barriers through survey research, education, and a planned series of initiatives targeting awareness, access, process, and policy.
Key Activities
IASLC (global professional society) runs biomarker testing work through its Partners for Thoracic Cancer Care collaboration, including the 2018 and 2024 Global Surveys on Biomarker Testing and using data from the surveys to conduct a planned series of initiatives addressing awareness, access, processes, and policy. IASLC has also conducted a global hospital-workflow study comparing approaches across countries (e.g., India, Poland, Canada) — non-US-specific.